首页>
外国专利>
гуманизованные antibodies specific for alpha - энолазе and ways of application in tumour тарапии
гуманизованные antibodies specific for alpha - энолазе and ways of application in tumour тарапии
展开▼
机译:对α-烯醇化酶特异的人源化抗体及其在肿瘤治疗中的应用方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A humanized antibody, or a binding fragment thereof, wherein the humanized antibody binds human ENOl (GenBank: AAH50642.1), wherein the antibody comprises a light chain variable region (VL) domain comprising a CDR1 having the amino acid sequence LCDR1 (RASENIYSYLT; SEQ ID NO:6) and a CDR2 having the amino acid sequence LCDR2 (NAKTLPE; SEQ ID NO:7) and a CDR3 having the amino acid sequence LCDR3 (QHHYGTPYT; SEQ ID NO: 8) and an antibody heavy chain variable region (VH) domain comprising a CDR1 having the amino acid sequence HCDR1 (GYTFTSCVMN; SEQ ID NO:3), a CDR2 having the amino acid sequence HCDR2 (YINPYNDGTKYNEKFKG; SEQ ID NO:4) and a CDR3 having the amino acid sequence HCDR3 (EGFYYGNFDN; SEQ ID NO: 5), wherein framework regions in the light chain variable region (VL) domain and the heavy chain variable region (VH) domain comprise amino acid sequences from a human immunoglobulin.
展开▼
机译:一种人源化抗体或其结合片段,其中所述人源化抗体结合人EN01(GenBank:AAH50642.1),其中所述抗体包含轻链可变区(VL)结构域,所述轻链可变区(VL)结构域包含具有氨基酸序列LCDR1(RASENIYSYLT; SEQ ID NO:6)和具有氨基酸序列LCDR2(NAKTLPE; SEQ ID NO:7)的CDR2和具有氨基酸序列LCDR3(QHHYGTPYT; SEQ ID NO:8)的CDR3和抗体重链可变区( VH)结构域,其包含具有氨基酸序列HCDR1(GYTFTSCVMN; SEQ ID NO:3)的CDR1,具有氨基酸序列HCDR2(YINPYNDGTKYNEKFKG; SEQ ID NO:4)的CDR2和具有氨基酸序列HCDR3(EGFYYGNFDN)的CDR3 ; SEQ ID NO:5),其中轻链可变区(VL)结构域和重链可变区(VH)结构域中的框架区包含来自人免疫球蛋白的氨基酸序列。
展开▼